维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="Tischkowitz M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Use of immunohistochemical markers can refine prognosis in triple negative breast cancer显示文摘	Tischkowitz M Brunet JS Begin LR	2007	BMC Cancer2007，7，：	1
2	Use of immunohisto- chemical markers can refine prognosis in triple negative breast cancer显示文摘	Tischkowitz M Brunet JS B6gin LR	2007	BMC Cancer2007，7134，：	1
3	Disruption of the Fanconi anemia - BRCA pathway in cisplatin - sen- sitive ovarian tumors 显示文摘	Taniguchi T Tischkowitz M Ameziane N	2003	Nat Med2003，9，：	1
4	Use of immunohistochemical markers can refine prognosis in triple- negative breast cancer 显示文摘	Tischkowitz M Brunet J S Begin L R	2007	BMC Cancer2007，7，1：	1
5	Use of immunohistochemical markers can refine prognosis in triple-negative breast cancer 显示文摘	Tischkowitz M Brunet JS Begin LR	2007	BMC Cancer2007，7，：	1
6	Use of immunohistochemical markers can refine prognosis in triple negative breastcancer显示文摘	Tischkowitz M Brunet JS Bégin LR	2007	BMCCancer2007，7，：	1
7	Use of immunohistochemical markes can refine prognosis in triple negative breast cancer显示文摘	Tischkowitz M Brunet JS Begin LR	2007	BMC Cancer2007，7，：	1
8	Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors显示文摘	TANIGUCHI T TISCHKOWITZ M AMEZIANE N	2003	Nat Med2003，9，5：	1
9	Use of immunohistochemical markers can refine prognosis in triple negative breast cancer显示文摘	Tischkowitz M Brunet JS Bégin LR	2007	BMC Cancer2007，7，：	1
10	Use of immuno-histo-chemical markers can refine prognosis in triple negative breast cancer显示文摘	Tischkowitz M Brunet J S Begin L R		0，，07：	1
11	Use of immunohistochemical markers can refine prognosis in triple negative breast cancer显示文摘	Tischkowitz M Brunet JS Begin LR	2007	BMC Cancer2007，7，：	1
12	Disruption of the Fanconi anemia - BRCA pathway in cisplatin - sensitive ovarian tumors显示文摘	Taniguchi T Tischkowitz M Ameziane N	2003	Nature Med2003，9，5：	1
13	Use of immunohis-tochemical markers can refine prognosis in triple negative breast caneer显示文摘	Tischkowitz M Brunet JS B6gin LR	2007	BMC Cancer2007，7，：	1
14	Bi - allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia显示文摘	Tischkowitz M Ameziane N Waisfisz Q	2003	Br J Haematnl2003，123，3：	1
15	Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors显示文摘	Taniguchi T Tischkowitz M Ameziane N	2003	Nat Med2003，9，5：	1
16	Use of immunohis- tochemical markers can refine prognosis in triple negative breast cancer显示文摘	Tischkowitz M Brunet JS Bgin LR	2007	BMC Cancer2007，7，：	1
17	Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors显示文摘	Taniguchi T Tischkowitz M Ameziane N	2003	Nat Med2003，9，5：	1
18	Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer,a phase 2,multicentre,open-label,non-randomised study显示文摘	Gelmon KA Tischkowitz M Mackay H		0，，09：	1
19	Use of immunohistochemical markers can refine prognosis in triple negative breast cancer显示文摘	Tischkowitz M Brunet JS Begin LR	2007	BMC Cancer2007，7，134：	1
20	miRNA processing and human cancer: DICER1 cuts the mustard 显示文摘	Bahubeshi A Tischkowitz M Foulkes WD	2011	Sci Transl Med2011，3，111：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示